While the regulator has not approved their use in type 1 diabetes, off-label prescribing for GLP-1 receptor agonists has sharply increased, according to researchers, who warn about the risk of serious side effects such as ketoacidosis
Always talk to a licensed healthcare provider before changing how you take any medication, including GLP-1s
Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4
However, there are other aspects to think about as well
J Clin Pharmacol 57:15191526 Hahn D, Stokes C, Kaiser R, Meyer M, Lammert F, Gruenhage F (2018) Antidepressant effects of direct-acting antivirals against hepatitis C virusresults from a pilot study